Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGND | CGON | APGE | ||
| Company | Ligand Pharm | Cg Oncology Inc | Apogee Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 112.06 | 27.58 | 46.48 | ||
| High | 115.47 | 28.94 | 48.42 | ||
| Low | 111.00 | 27.58 | 45.51 | ||
| Last | 114.64 | 28.67 | 47.71 | ||
| Change | +0.69 | +0.65 | +0.69 | ||
| % Change | +0.61% | +2.32% | +1.47% | ||
| Volume | 551,500 | 1,470,700 | 606,200 | ||
| 20-Day Average Volume | 134,835 | 932,050 | 623,035 | ||
| Previous Close | 113.94 | 28.02 | 47.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 119.58 | 32.24 | 46.62 | ||
| 20-Day Raw Stochastic | 21.59% | 17.16% | 49.81% | ||
| 20-Day Relative Strength | 48.65% | 36.49% | 48.26% | ||
| Weighted Alpha | +60.24 | -24.36 | +2.65 | ||
| Today's Opinion | 64% Buy | 72% Sell | 40% Sell | ||
| Previous Opinion | 64% Buy | 72% Sell | 40% Sell | ||
| Last Month's Opinion | 88% Buy | 40% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.94% since 12/13/24 | -0.31% since 12/13/24 | +7.21% since 12/13/24 | ||
| Low | 111.00 on 12/20/24 | 27.00 on 12/19/24 | 43.69 on 12/18/24 | ||
| High | 124.03 on 12/16/24 | 30.00 on 12/18/24 | 48.85 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | +2.76% since 11/20/24 | -11.07% since 11/20/24 | +5.93% since 11/20/24 | ||
| Low | 111.00 on 12/20/24 | 27.00 on 12/19/24 | 41.85 on 12/13/24 | ||
| High | 127.86 on 12/06/24 | 36.73 on 12/04/24 | 53.62 on 12/04/24 | ||
| 3-Month | |||||
| %Chg | +11.52% since 09/20/24 | -26.49% since 09/20/24 | -18.35% since 09/20/24 | ||
| Low | 96.96 on 09/27/24 | 27.00 on 12/19/24 | 41.85 on 12/13/24 | ||
| High | 129.90 on 11/07/24 | 40.47 on 11/11/24 | 63.50 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +43.64% since 06/20/24 | -10.71% since 06/20/24 | +25.39% since 06/20/24 | ||
| Low | 77.53 on 06/26/24 | 27.00 on 12/19/24 | 36.43 on 06/26/24 | ||
| High | 129.90 on 11/07/24 | 40.47 on 11/11/24 | 63.50 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,166,123 | 2,180,010 | 2,148,238 | ||
| Shares Outstanding, K | 18,895 | 76,038 | 45,027 | ||
| Annual Sales | 131,310,000 | 200,000 | 0 | ||
| Annual Net Income | 52,150,000 | -48,610,000 | -83,990,000 | ||
| Last Quarter Sales | 51,810,000 | 40,000 | 0 | ||
| Last Quarter Net Income | -7,170,000 | -20,410,000 | -49,020,000 | ||
| 60-Month Beta | 1.01 | N/A | 2.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/07/24 | -0.30 on 11/12/24 | -0.86 on 11/12/24 | ||
| Latest Earnings Date | 11/07/24 | 11/14/24 | 11/11/24 | ||
| Most Recent Dividend | 2.500 on 04/03/07 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 53.75 | 0.00 | 0.00 | ||